NF-κB activation has been identified in several human cancers, including but not limited to lymphoma, colorectal tumors, esophageal and head and neck carcinoma, breast tumors, hepatocellular carcinoma, and prostate cancer [10–16]. This evidence concerns the gene NFKB1 and prostate cancer.